Tatiana C. Coverdell

Jul 3, 2024 | onlinelibrary.wiley.com | Tatiana C. Coverdell |Haneen Shalabi |Nirali Shah |Roa Harb

CAR chimeric antigen receptor CRS cytokine release syndrome ICU intensive care unit IEC-HS immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome 1 INTRODUCTION Chimeric antigen receptor (CAR) T-cell therapy is associated with a host of inflammatory conditions, including cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and the more recently described immune effector cell-associated hemophagocytic...

Apr 30, 2024 | myadlm.org | Tatiana C. Coverdell

Low-density lipoprotein cholesterol (LDL-C) is used to assess Atherosclerotic Cardiovascular Disease (ASCVD) risk and to manage lipid-lowering therapy. Proprotein convertase subtilisin/kexin (type 9) serine protease (PCSK9) inhibitors are an emerging therapeutic option for decreasing LDL-C levels.